Segment disclosures

Company overview

Nordion Inc.

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

8 dimension combinations 29 retained observations 5 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

MSA Revenue · Medical Isotopes

Income Statement Location · Statement Business Segments

Source dimensions us-gaap:IncomeStatementLocationAxis=ndz:MSARevenueMember;us-gaap:StatementBusinessSegmentsAxis=ndz:MedicalIsotopesMember
PeriodValueUnitFiledEvidence
2012-11-01 – 2013-10-313800000 USD20140109Open filing evidence

Medical Isotopes

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=ndz:MedicalIsotopesMember
PeriodValueUnitFiledEvidence
2012-11-01 – 2013-10-31100348000 USD20140109Open filing evidence
2011-11-01 – 2012-10-31100955000 USD20140109Open filing evidence
2010-11-02 – 2011-10-31122789000 USD20140109Open filing evidence
2010-11-01 – 2011-10-31103533000 USD20120113Open filing evidence
2009-11-01 – 2010-10-3157594000 USD20120113Open filing evidence
2008-11-01 – 2009-10-3194003000 USD20120113Open filing evidence

Specialty Isotopes Medical Isotopes

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=ndz:SpecialtyIsotopesMedicalIsotopesMember
PeriodValueUnitFiledEvidence
2011-11-01 – 2012-10-31100955000 USD20130128Open filing evidence
2010-11-01 – 2011-10-31122789000 USD20130128Open filing evidence
2009-11-01 – 2010-10-3189372000 USD20130128Open filing evidence

Specialty Isotopes Sterilization Technologies

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=ndz:SpecialtyIsotopesSterilizationTechnologiesMember
PeriodValueUnitFiledEvidence
2011-11-01 – 2012-10-3195434000 USD20130128Open filing evidence
2010-11-01 – 2011-10-31108662000 USD20130128Open filing evidence
2009-11-01 – 2010-10-31103556000 USD20130128Open filing evidence

Sterilization Technologies

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=ndz:SterilizationTechnologiesMember
PeriodValueUnitFiledEvidence
2012-11-01 – 2013-10-3196120000 USD20140109Open filing evidence
2011-11-01 – 2012-10-3195434000 USD20140109Open filing evidence
2010-11-02 – 2011-10-31108662000 USD20140109Open filing evidence
2010-11-01 – 2011-10-31108662000 USD20120113Open filing evidence
2009-11-01 – 2010-10-31103556000 USD20120113Open filing evidence
2008-11-01 – 2009-10-3178322000 USD20120113Open filing evidence

Targeted Therapies

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=ndz:TargetedTherapiesMember
PeriodValueUnitFiledEvidence
2012-11-01 – 2013-10-3136322000 USD20140109Open filing evidence
2011-11-01 – 2012-10-3148451000 USD20140109Open filing evidence
2010-11-02 – 2011-10-3142576000 USD20140109Open filing evidence
2010-11-01 – 2011-10-3142576000 RestatedUSD20130128Open filing evidence
2009-11-01 – 2010-10-3129040000 RestatedUSD20130128Open filing evidence
2008-11-01 – 2009-10-3139372000 USD20120113Open filing evidence

TSA Revenue

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=ndz:TSARevenueMember
PeriodValueUnitFiledEvidence
2012-11-01 – 2013-10-31500000 USD20140109Open filing evidence

Unallocated Amount To Segment

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=us-gaap:UnallocatedAmountToSegmentMember
PeriodValueUnitFiledEvidence
2010-11-01 – 2011-10-310 USD20120113Open filing evidence
2009-11-01 – 2010-10-310 USD20120113Open filing evidence
2008-11-01 – 2009-10-310 USD20120113Open filing evidence